3859 results for «2025»

Filter By

3859 results

Transforming PCI: mastering the implementation of drug-eluting balloons

22 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session provides a comprehensive overview of drug-eluting balloons (DEBs) and their growing role in percutaneous coronary intervention (PCI). Gain a clear understanding of the clinical evidence and rationale supporting DEBs, including how these devices minimize metal implantation and effectively treat both standard and...

Transforming PCI: mastering the implementation of drug-eluting balloons

Active posterior leaflet replacement - A novel transcatheter approach for the treatment of primary and secondary mitral regurgitation

21 May 2025 – From EuroPCR 2025

Find out more about an innovative transcatheter strategy for managing both primary and secondary mitral regurgitation in this EuroPCR 2025 session. Experts introduce the concept of active posterior leaflet replacement and present the Polares MRace device—a novel solution designed to address the limitations of current therapies....

Active posterior leaflet replacement - A novel transcatheter approach for the treatment of primary and secondary mitral regurgitation

Advancing renal denervation in China: from guidelines to practice

20 May 2025 – From EuroPCR 2025

Discover how renal denervation (RDN) is rapidly evolving in China to meet the needs of patients with uncontrolled hypertension. This EuroPCR 2025 session highlights recent guideline endorsements and approvals, patient selection based on drug resistance and cardiovascular risk, and the critical role of diagnostic screening. Gain...

Advancing renal denervation in China: from guidelines to practice

Cardiogenic shock and high-risk interventions with percutaneous mechanical circulatory support: new evidence and insights

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session offers a comprehensive update on cardiogenic shock and high-risk PCI, featuring expert analysis of the DanGer-SHOCK and ECLS-SHOCK trials, new insights one year after DanGer-SHOCK, and practical considerations for managing PCI in patients with severely reduced LVEF. Expect to gain a deeper...

Cardiogenic shock and high-risk interventions with percutaneous mechanical circulatory support: new evidence and insights

From imaging to intervention: cutting-edge solutions for calcified coronary stenoses management

20 May 2025 – From EuroPCR 2025

Watch this EuroPCR 2025 session on managing calcified coronary stenoses, featuring a recorded live case, two focused lectures, and expert faculty insights. Learn why intravascular ultrasound (IVUS) is essential for assessing lesion severity and morphology, discover how selecting the right calcium modification tools drives procedural success...

From imaging to intervention: cutting-edge solutions for calcified coronary stenoses management

From innovation to integration: the evolution of 4D intracardiac echocardiography in structural heart interventions

21 May 2025 – From EuroPCR 2025

Learn how 4D intracardiac echocardiography (ICE) is reshaping structural heart procedures. This EuroPCR 2025 session takes you through the latest in imaging technology—highlighting the benefits of 4D ICE and AI integration in improving the safety, precision, and efficiency of mitral and tricuspid interventions. From valve repair...

From innovation to integration: the evolution of 4D intracardiac echocardiography in structural heart interventions

Innovations in TMVR and Intrepid trial updates

21 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session highlights the evolving role of transcatheter mitral valve replacement, focusing on the clinical potential of mitral regurgitation elimination. Get an overview of the current status of the Intrepid TMVR programme, learn about the transition to the 29Fr transfemoral system, and explore how...

Innovations in TMVR and Intrepid trial updates

Treating complex CAD indications with sirolimus coated balloon: evidence and performance

22 May 2025 – From EuroPCR 2025

Gain a deeper understanding of how sirolimus coated balloon (SCB) technology is shaping the treatment of complex coronary artery disease (CAD). This EuroPCR 2025 session brings together compelling clinical trial data and real-world case presentations to illustrate the safety, efficacy, and versatility of the MagicTouch SCB...

Treating complex CAD indications with sirolimus coated balloon: evidence and performance

Novel Hertz Contact Intravascular Lithotripsy: could we achieve more in calcium modification?

22 May 2025 – From EuroPCR 2025

Discover how the novel Hertz Contact Intravascular Lithotripsy (IVL) is pushing the boundaries of calcium modification in challenging coronary lesions.

This EuroPCR 2025 session shares real-world insights confirming the promising results of the PINNACLE I trial, with LithiX IVL proving safe and effective across eccentric, concentric, and...

Novel Hertz Contact Intravascular Lithotripsy: could we achieve more in calcium modification?

Optimising self-expandable TAVI clinical outcomes without compromise

22 May 2025 – From EuroPCR 2025

Optimising patient outcomes in self-expandable TAVI starts with a clear plan for today, and tomorrow. This EuroPCR 2025 session explores how to make each step count, from access to implantation and closure, using a real-life case of a 77-year-old woman with severe symptomatic aortic stenosis and...

Optimising self-expandable TAVI clinical outcomes without compromise

The new global era of patient care with CathWorks FFRangio

22 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session highlights how CathWorks FFRangio is reshaping coronary physiology assessment worldwide. Through case-based experience and real-world data, it showcases the integration of FFRangio into routine clinical workflows—from early adoption at Clinique Pasteur in Toulouse to implementation across the UK. The session also presents...

The new global era of patient care with CathWorks FFRangio

Mastering techniques from basic to complex - TEER for degenerative mitral regurgitation and complex situations

07 Feb 2025 – From PCR Tokyo Valves 2025

Explore the complexities of transcatheter edge-to-edge repair (TEER) for degenerative mitral regurgitation in this PCR Tokyo Valves 2025 session. Gain insights into anatomical challenges, key procedural steps, and expert strategies for managing complex cases. Compare MitraClip and PASCAL for degenerative MR, learn how to handle commissural...

Mastering techniques from basic to complex - TEER for degenerative mitral regurgitation and complex situations

Lifetime management

08 Feb 2025 – From PCR Tokyo Valves 2025

This PCR Tokyo Valves 2025 session explores the latest insights into TAVR explantation. It begins with the management of patients with longer life expectancy, then delves into surgical aortic valve replacement, aortic root enlargement, and commissural alignment—key techniques that may improve reintervention outcomes. The session also...

Lifetime management

TAVI unplugged: multidisciplinary insights on roles and teamwork

08 Feb 2025 – From PCR Tokyo Valves 2025

Successful TAVI procedures rely on more than just technical expertise—they require seamless teamwork across specialties. In this session PCR Tokyo Valves 2025, discover the crucial roles of radiologists and nurses in the preoperative and intraoperative phases of TAVI. Through live case analysis and shared experiences, gain...

TAVI unplugged: multidisciplinary insights on roles and teamwork

Sirolimus coated balloon for coronary artery disease and peripheral artery disease treatment: the new frontier

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session delivers a comprehensive update on the MagicTouch sirolimus-coated balloon (SCB) and its expanding role in treating both coronary and peripheral artery disease (CAD/PAD). The session covers the extensive clinical trial program supporting MagicTouch as a versatile treatment option across multiple indications. It...

Sirolimus coated balloon for coronary artery disease and peripheral artery disease treatment: the new frontier

Sharper views, smarter moves: mini 4D TEE and 4D ICE in structural heart interventions

09 Feb 2025 – From PCR Tokyo Valves 2025

Don’t miss this PCR Tokyo Valves 2025 session replay, where experts dive into the clinical benefits of the Mini 4D TEE Probe in TAVR and LAAC procedures. Learn how this miniaturised probe enhances patient outcomes in TAVR, contributing to more efficient procedures and improved safety. Discover...

Sharper views, smarter moves: mini 4D TEE and 4D ICE in structural heart interventions

A simple low profile solution to the pulmonary embolism problem: EKOS

21 May 2025 – From EuroPCR 2025

Discover a streamlined approach to pulmonary embolism treatment in this EuroPCR 2025 session. Learn how ultrasound-assisted thrombolysis improves right ventricular function and pulmonary perfusion while enabling timely reperfusion with low-dose thrombolytic therapy delivered directly to the clot. Explore the latest data from the HI-PEITHO randomised trial...

A simple low profile solution to the pulmonary embolism problem: EKOS

Advanced imaging in structural heart disease interventions

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session brings together expert insights on the evolving role of 3D intracardiac echocardiography (ICE) in procedures like LAA closure, Mitral TEER, and Tricuspid TEER—highlighting how this advanced modality is reshaping procedural guidance.

You'll also discover how AI-enabled device detection technology is being integrated into...

Advanced imaging in structural heart disease interventions

Align for the future with the Myval Octapro transcatheter heart valve series

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session offers a practical and evidence-based update on the Myval Octapro THV. Learn step-by-step techniques for valve-in-valve TAVI using the OctaAlign approach, and understand how intermediate sizes and precise deployment contribute to optimised hemodynamics and long-term durability.

Clinical insights are backed by key data...

Align for the future with the Myval Octapro transcatheter heart valve series

Broadening OPTIONs for LAA closure: innovations and outcomes

20 May 2025 – From EuroPCR 2025

Explore the latest insights into LAA closure from EuroPCR 2025. This session highlights results from the OPTION trial—the largest RCT comparing LAAC (with Watchman FLX) to DOAC therapy in AF patients undergoing ablation. The findings? Comparable stroke prevention at 3 years, with a 56 % reduction...

Broadening OPTIONs for LAA closure: innovations and outcomes
Didn’t find what you were looking for?